Target intelligence / Profile preview

Organic anion transporting polypeptide 1B1 (OATP1B1), 1B3 (OATP1B3), and 2B1 (OATP2B1) (OATP1B1/1B3/2B1)

Target
OATP1B1/1B3/2B1
Molecular classification
Transporter, Solute carrier family 21 (SLC21), Solute carrier organic anion (SLCO) family
01

Overview

Organic anion transporting polypeptides 1B1, 1B3, and 2B1 are critical membrane transporters belonging to the SLCO superfamily, primarily localized on the sinusoidal (basolateral) membrane of human hepatocytes [1, 2]. They facilitate the sodium-independent uptake of a diverse array of endogenous substances, such as bilirubin, bile acids, and steroid conjugates, as well as numerous clinically important drugs, including statins, antivirals, and chemotherapeutic agents [3, 11]. OATP1B1 and OATP1B3 are exclusively expressed in the liver, while OATP2B1 has a broader tissue distribution including the intestine and blood-brain barrier [4, 8]. These transporters play a pivotal role in the first-pass effect and overall hepatic clearance of their substrates [15]. Genetic variations, such as the SLCO1B1*5 polymorphism, or pharmacological inhibition by drugs like cyclosporine or rifampin, can lead to markedly increased plasma concentrations of substrate drugs, significantly raising the risk of adverse effects like statin-induced myopathy or rhabdomyolysis [7, 10]. Due to their profound impact on pharmacokinetics and safety, they are recognized by regulatory agencies as key targets for evaluating drug-drug interaction potential during drug development [9, 12].

Other names
SLCO1B1SLCO1B3SLCO2B1Solute carrier organic anion transporter family member 1B1Solute carrier organic anion transporter family member 1B3Solute carrier organic anion transporter family member 2B1Liver-specific organic anion transporter 1 (LST-1)OATP-COATP-8OATP-2
02

Mechanism of action

These proteins function as sodium-independent uptake transporters that facilitate the diffusion of amphipathic organic anions across the basolateral membrane of hepatocytes. Drugs targeting or interacting with these transporters typically act as substrates (undergoing hepatic clearance) or inhibitors (blocking the uptake of other drugs, leading to increased systemic exposure and potential toxicity).

03

Biological functions

Hepatic uptake of endogenous and exogenous compoundsBile acid transportBilirubin transportSteroid hormone transportThyroid hormone transportDrug disposition and elimination
04

Disease associations

Hyperbilirubinemia (Rotor syndrome)Statin-induced myopathyRhabdomyolysisDrug-induced liver injury (DILI)Cancer (chemotherapy resistance and disposition)
05

Safety considerations

Clinically significant drug-drug interactions (DDIs)Increased risk of systemic toxicity (e.g., myotoxicity) due to transporter inhibitionGenetic polymorphisms leading to inter-individual variability in drug clearancePotential for severe adverse events like rhabdomyolysis when co-administered with potent inhibitors
06

Interacting drugs

Atorvastatin

14 more in the full profile.

07

Biomarkers

Coproporphyrin I (CP-I)Coproporphyrin III (CP-III)Unconjugated bilirubinConjugated bilirubinSLCO1B1*5 (c.521T>C) genetic variant

Beyond the preview

Go deeper on Organic anion transporting polypeptide 1B1 (OATP1B1), 1B3 (OATP1B3), and 2B1 (OATP2B1) (OATP1B1/1B3/2B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Organic anion transporting polypeptide 1B1 (OATP1B1), 1B3 (OATP1B3), and 2B1 (OATP2B1) (OATP1B1/1B3/2B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call